dosage form factors Flashcards
The bioavailability of a given drug tends to decrease in the
following order of types of dosage form: aqueous
solutions > aqueous suspensions > solid dosage forms
Factors associated with the formulation of aqueous solutions that can influence drug bioavailability include:
• The chemical stability exhibited by the drug in aqueous
solution and the gastrointestinal fluids.
• Complexation, i.e. the formation of a complex between the
drug and an excipient included to increase
• The aqueous solubility of the drug
• The chemical stability of the drug
• Viscosity of the dosage form
• Solubilization, i.e. the incorporation of the drug into
micelles in order to increase its aqueous solubility
• The viscosity of a solution dosage form, particularly if a
viscosity-enhancing agent has been included.
remember
aqueous solution= no dissolution
the aquoues solution might precipitate into a fine powder that is ready to be re absorbed just like weak acid salts
what is a suspension
An aqueous suspension is a useful dosage form for administering an
insoluble or poorly water-soluble drug.
• Usually the absorption of a drug from this type of dosage form is
dissolution-rate limited.
whats the difference between gelatin capsule and suspension
In contrast to powder-filled hard gelatin capsule and
tablet dosage forms, dissolution of all drug particles starts
immediately upon dilution of the suspension in the
gastrointestinal fluids.
• A drug contained in a tablet or hard gelatin capsule may
ultimately achieve the same state of dispersion in the
gastrointestinal fluids, but only after a delay
(disintegration)
Factors associated with the formulation of aqueous
suspension dosage forms that can influence the
bioavailabilities of drugs from the gastrointestinal tract
include:
• The particle size and effective surface area of the
dispersed drug
• The crystal form of the drug
• Any resulting complexation, i.e. the formation of a
non-absorbable complex between the drug and an
excipient such as the suspending agent
• The inclusion of a surfactant as a wetting or
flocculating agent
• The viscosity of the suspension.
what kind of vehicles do we use for liquid-filled capsules
Drugs encapsulated in liquid-filled capsules for peroral administration are dissolved or dispersed
in non-toxic, non-aqueous vehicles.
• Such vehicles may be water immiscible (i.e. lipophilic) or water miscible (i.e. hydrophilic).
• Vegetable oils are popular water-immiscible vehicles
• Polyethylene glycols and certain non-ionic surfactants (e.g. polysorbate-80) are water miscible.
• Sometimes the vehicles have thermal properties such that they can be filled into capsules while
hot, but are solids at room temperatur
what happens after the release of the drug from the capsule
• A water-miscible vehicle disperses and/or dissolves readily
in the gastrointestinal fluids liberating the drug
(depending on its aqueous solubility) as either a solution or
a fine suspension rapid absorption.
• Gelatin capsules containing drugs in solution or suspension
in water-immiscible vehicles release of the contents will
almost certainly be followed by dispersion in the
gastrointestinal fluids.
• Dispersion is facilitated by emulsifiers included in the vehicle, and
also by bile.
• Once dispersed the drug may end up as an emulsion, a solution,
a fine suspension or a microemulsion.
• Well formulated liquid-filled capsules aimed at improving
the absorption of poorly soluble drugs will ensure that no
precipitation of drug occurs from the microemulsion in
the gastrointestinal fluids.
• If the lipophilic vehicle is a digestible oil and the drug is
highly soluble in the oil:
s.
• It is possible that the drug will remain in solution in
the dispersed oil phase and be absorbed (along
with the oil) by fat absorption processes
For a drug that is less lipophilic or is dissolved in a nondigestible oil:
Absorption probably occurs following partitioning of the
drug from the oily vehicle into the aqueous gastrointestinal
fluids.
• In this case, the rate of drug absorption appears to depend
on the rate at which drug partitions from the dispersed oil
phase.
• The increase in interfacial area of contact resulting from
dispersion of the oily vehicle in the gastrointestinal fluids
will facilitate partition of the drug across the oil/aqueous
interface.
• For drugs suspended in an oily vehicle, release may involve
dissolution in the vehicle, diffusion to the oil/aqueous
interface and partition across the interface
Factors associated with the formulation of liquid filled
gelatin capsules which can influence the bioavailabilities
of drugs from this type of dosage form include:
• The solubility of the drug in the vehicle
• The solubility of the drug in gastrointestinal fluids
• The particle size of the drug (if suspended in the
vehicle)
• The nature of the vehicle, i.e. hydrophilic or lipophilic
• If lipophilic vehicle is used: is it a digestible or a
non-digestible oil.
• The inclusion of a surfactant as a wetting/emulsifying
agent in a lipophilic vehicle or as the vehicle itself
• The inclusion of a suspending agent (viscosity
enhancing agent) in the vehicle
• The complexation, i.e. formation, of a nonabsorbable
complex between the drug and any excipient.
what is better: powder filled capsules or tablets and why
powder filled capsules due to
the hard gelatin shell dissolves rapidly in the
gastrointestinal fluids
• The encapsulated mass disperses rapidly and efficiently a relatively
large effective surface area of drug will be exposed to the
gastrointestinal fluids, thereby facilitating dissolution
the rate of drug dissolution from a hard capsule gets affected by
• The dissolution rate of the gelatin shell
• The rate of penetration of the gastrointestinal fluids into
the encapsulated mass
• The rate at which the mass deaggregates (i.e. disperses) in
the gastrointestinal fluids
• The rate of dissolution of the dispersed drug particles
• The inclusion of excipients (e.g. diluents, lubricants and
surfactants) in a capsule formulation can have a significant
effect on the rate of dissolution of drugs, particularly those
that are poorly soluble and hydrophobic.
• The hydrophilic diluent (e.g. sorbitol, lactose) often serves to
increase the rate of penetration of the aqueous
gastrointestinal fluids into the contents of the capsule and
to aid the dispersion and subsequent dissolution of the drug in
these fluids.
• However, the diluent should exhibit no tendency to adsorb or
complex with the drug, as either can impair absorption from
the gastrointestinal tract.
whats the relation between packing density and dissolution rate in powder filled capsules
In general, an increase in packing density (i.e. a
decrease in porosity) of the encapsulated mass will
probably result in a decrease in liquid permeability
and dissolution rate
• Particularly if the drug is hydrophobic, or if a
hydrophilic drug is mixed with a hydrophobic
lubricant such as magnesium stearate.
Formulation factors that can influence the
bioavailabilities of drugs from hard gelatin capsules
include:
• The surface area and particle size of the drug
• The use of the salt form of a drug in preference to the
parent weak acid or base
• The crystal form of the drug
• The chemical stability of the drug (in the dosage form and
in gastrointestinal fluids)
• The nature and quantity of the diluent, lubricant and
wetting agent
• Drug-excipient interactions (e.g. adsorption, complexation)
• The type and conditions of the filling process
• The packing density of the capsule contents
• The composition and properties of the capsule shell
(including enteric capsules)
• Interactions between the capsule shell and its contents
• When a drug is formulated as a compressed tablet there is an
enormous reduction in the effective surface area of the drug, owing to
the granulation and compression processes involved in tablet making. how can we solve this
• These processes necessitate the addition of excipients, which serve to
return the surface area of the drug back to its original precompressed
state.
• If a fine, well dispersed suspension of drug particles in the
gastrointestinal fluids is not generated following the administration of a
tablet Bioavailability problems can arise
The overall rate of tablet disintegration is influenced by
several interdependent factors which include
• The concentration and type of drug
• The concentration and type of diluent
• The concentration and type of binder
• The concentration and type of disintegrant
• The concentration and type of lubricant
• The concentration and type of wetting agent
• The compaction pressure
Poor disintegration will lead to poor dissolution.
what is thw rate limiting step for poorly soluble drugs tablets
the rate-controlling
step is usually the overall rate of dissolution of the
liberated drug particles in the gastrointestinal fluids (not
the disintegration) .
The overall dissolution rate and bioavailability of a
poorly soluble drug from an uncoated conventional
tablet is influenced by many factors associated with
the formulation and manufacture of this type of
dosage form. These include:
• The physicochemical properties of the liberated drug
particles in the gastrointestinal fluids, e.g. wettability,
effective surface area, crystal form, chemical stability
• The nature and quantity of the diluent, binder, disintegrant,
lubricant and any wetting agent
• Drug-excipient interactions (e.g. complexation),
• The size of the granules and their method of manufacture
• The compaction pressure and speed of compression used
in tableting
• The conditions of storage and age of the tablet
Tablet coatings may be used simply for aesthetic reasons to:
• Improve the appearance of a tablet
• Add a company logo
• Mask an unpleasant taste or odor
• Protect an ingredient from decomposition during storage.
why do coated tablets have more problems
The presence of a coating presents a physical barrier between
the tablet core and the gastrointestinal fluids:
• coated tablets therefore not only possess all the potential
bioavailability problems associated with uncoated
conventional tablets but are subject to the additional
potential problem of being surrounded by a physical
barrier.
The physicochemical nature and thickness of the coating can
thus influence how quickly a drug is released from a tablet.
The physicochemical nature and thickness of the coating can
thus influence how quickly a drug is released from a tablet.